SYMBOL:

    Up to 100 tickers separated by a space
Site Map FAQ Contact us Home Personalize
Company
Industry
Earnings
US Markets
Most Active
Portfolio
Tools
FACET BIOTECH CORPORATION
(NASDAQ:FACT Last Sale: 27.01 )
Fundamentals Charts Tech Analysis Industry Earnings
Company Profile   Details

Company Web Site
NASDAQ: (FACT : $27.01)
$678 million Market Cap at Market Close, April 21, 2010
Biomedics SubIndustry down < .38%> / Health Industry down < .37> Today
1500 Seaport Boulevard Research Report Earnings Snapshot - Last
Redwood City, CA 94063 Annual Reports
Phone: 650-454-1000

Faheem Hasnain, CEO/Pres., Andrew L. Guggenhime, CFO
Agreed to be acquired for $722 million by Abbott Laboratories (ABT) March 9, 2010. Holders receive $27 per share. Rejected $14.50 per share acquisition offer from BIOGEN IDEC (BIIB) September 8, 2009. Focused on treatment for multiple sclerosis. Formed as a Spin-off by PDL BIOPHARMA INC (PDLI) as (FACT) effective December 18, 2008; when-issued trading as (FACTV) started December 10, 2008. PDLI announced spin off and separate listing of biotechnology business April 10, 2008.
Historical Charts    Technical Analysis

Type of Stock Symbol Last Sale Last Close Net +/- % +/- Low High Volume 52wk Low 52wk High Shares(M)
Common FACT $27.01 $ 0 $26.99 $27.01 27,215 $7.61 $27.03 25,093
Capitalization
Earnings Summary
*** No Earnings Available***
-10046
Common Stock $677,762

Split, Dividend and Symbol Change Information
Date Symbol Transaction Dividend Split New Symbol
19-DEC-08 FACTV Symbol Changed to FACT

A
Google



QUICK NAVIGATION SITE SEARCH   Enter Keyword:
   
Home    Subscribe    Browser Help    Subscriber Services    B-to-B    Banks    Brokerage    Telco    Site Map    Legal    Contact/Email
Copyright © 1996 - 2010 Stock Smart with all rights reserved
Quotes are delayed 15 minutes or more for Nasdaq, 20 minutes or more for NYSE/AMEX. Provided by TTI